Gilead Sciences: New Report Shows Every Country in the World Must Do More To End the HIV Epidemic
A new report titled 'Going the Extra Mile to End the HIV Epidemic' highlights that every country worldwide must do more to end the HIV epidemic. The report, commissioned by Gilead Sciences (GILD), offers a roadmap to help countries achieve the United Nations' goal of eliminating HIV by 2030. Despite having the necessary tools and resources, no country is close to this goal.
The report examines programs in nine Western countries and emphasizes the need for national strategies focused on four key areas: broader use of prevention, large-scale screening for diagnosis, expansion of community-based care, and use of tools to measure quality of life. It also addresses social factors like stigma, discrimination, and health equity that hinder progress.
The authors stress that while scientific innovation and healthcare access have improved, millions still live with HIV globally. They call for urgent action in the next five years to make significant progress in prevention, testing, and treatment of HIV.
Un nuovo rapporto intitolato 'Impegnarsi per porre fine all'epidemia di HIV' evidenzia che ogni paese nel mondo deve fare di più per porre fine all'epidemia di HIV. Il rapporto, commissionato da Gilead Sciences (GILD), offre una roadmap per aiutare i paesi a raggiungere l'obiettivo delle Nazioni Unite di eliminare l'HIV entro il 2030. Nonostante dispongano degli strumenti e delle risorse necessarie, nessun paese è vicino a questo obiettivo.
Il rapporto esamina i programmi in nove paesi occidentali e sottolinea la necessità di strategie nazionali focalizzate su quattro aree chiave: uso più ampio della prevenzione, screening su larga scala per la diagnosi, espansione dell'assistenza basata sulla comunità e utilizzo di strumenti per misurare la qualità della vita. Affronta anche fattori sociali come stigma, discriminazione e equità nella salute che ostacolano i progressi.
Gli autori sottolineano che, sebbene l'innovazione scientifica e l'accesso alle cure siano migliorati, milioni di persone vivono ancora con l'HIV nel mondo. Chiedono un'azione urgente nei prossimi cinque anni per fare progressi significativi nella prevenzione, nel test e nel trattamento dell'HIV.
Un nuevo informe titulado 'Comprometernos a poner fin a la epidemia de VIH' destaca que cada país en todo el mundo debe hacer más para poner fin a la epidemia de VIH. El informe, encargado por Gilead Sciences (GILD), ofrece una hoja de ruta para ayudar a los países a alcanzar el objetivo de las Naciones Unidas de eliminar el VIH para el 2030. A pesar de contar con las herramientas y recursos necesarios, ningún país está cerca de este objetivo.
El informe examina programas en nueve países occidentales y enfatiza la necesidad de estrategias nacionales centradas en cuatro áreas clave: uso más amplio de la prevención, diagnostico a gran escala, expansión de la atención comunitaria y uso de herramientas para medir la calidad de vida. También aborda factores sociales como el estigma, la discriminación y la equidad en salud que obstaculizan el progreso.
Los autores enfatizan que, aunque la innovación científica y el acceso a la atención médica han mejorado, millones de personas aún viven con VIH en todo el mundo. Hacen un llamado a la acción urgente en los próximos cinco años para lograr avances significativos en la prevención, pruebas y tratamiento del VIH.
새로운 보고서 'HIV 유행 종식을 위한 추가적인 노력'는 전 세계 모든 국가가 HIV 유행 종식을 위해 더 많은 노력을 해야 한다고 강조합니다. 길리어드 사이언스(GILD)가 의뢰한 이 보고서는 각국이 2030년까지 HIV를 없애겠다는 유엔의 목표를 달성하는 데 도움이 되는 로드맵을 제공합니다. 필요한 도구와 자원이 있음에도 불구하고, 어느 나라도 이 목표에 가까운 상황이 아닙니다.
보고서는 아홉 개 서구 국가의 프로그램을 검토하고, 예방의 폭넓은 사용, 대규모 진단 스크리닝, 지역 사회 기반 치료의 확장, 삶의 질 측정 도구 사용의 네 가지 핵심 영역에 초점을 맞춘 국가 전략이 필요하다고 강조합니다. 또한 진전을 저해하는 사회적 요인인 낙인, 차별, 건강 공평성 등을 다룹니다.
저자들은 과학 혁신과 의료 접근이 개선되었음에도 불구하고 전 세계적으로 여전히 수백만 명이 HIV와 함께 살아가고 있다고 강조합니다. 그들은 예방, 검사 및 치료에서 Significant한 진전을 이루기 위해 향후 5년 동안 긴급한 행동을 촉구합니다.
Un nouveau rapport intitulé 'Aller au-delà des efforts pour mettre fin à l'épidémie de VIH' met en lumière que chaque pays dans le monde doit faire plus pour mettre fin à l'épidémie de VIH. Le rapport, commandé par Gilead Sciences (GILD), propose une feuille de route pour aider les pays à atteindre l'objectif des Nations Unies d'éliminer le VIH d'ici 2030. Malgré les outils et ressources nécessaires, aucun pays n'est proche de cet objectif.
Le rapport examine des programmes dans neuf pays occidentaux et souligne la nécessité de stratégies nationales axées sur quatre domaines clés : utilisation élargie de la prévention, dépistage à grande échelle pour le diagnostic, expansion des soins basés sur la communauté et utilisation d'outils pour mesurer la qualité de vie. Il aborde également des facteurs sociaux tels que la stigmatisation, la discrimination et l'équité en santé qui entravent le progrès.
Les auteurs soulignent que, bien que l'innovation scientifique et l'accès aux soins se soient améliorés, des millions de personnes vivent encore avec le VIH dans le monde. Ils appellent à des actions urgentes au cours des cinq prochaines années pour réaliser des progrès significatifs en matière de prévention, de dépistage et de traitement du VIH.
Ein neuer Bericht mit dem Titel 'Zusätzliche Anstrengungen zur Beendigung der HIV-Epidemie' hebt hervor, dass jedes Land weltweit mehr tun muss, um die HIV-Epidemie zu beenden. Der Bericht, der von Gilead Sciences (GILD) in Auftrag gegeben wurde, bietet einen Fahrplan, um den Ländern zu helfen, das Ziel der Vereinten Nationen zu erreichen, bis 2030 HIV zu beseitigen. Trotz der verfügbaren Werkzeuge und Ressourcen ist kein Land diesem Ziel nahe.
Der Bericht untersucht Programme in neun westlichen Ländern und betont die Notwendigkeit nationaler Strategien, die auf vier zentrale Bereiche fokussiert sind: erweiterte Nutzung von Prävention, großflächiges Screening zur Diagnostik, Ausbau der gemeindebasierten Pflege und Einsatz von Werkzeugen zur Messung der Lebensqualität. Er behandelt auch soziale Faktoren wie Stigma, Diskriminierung und gesundheitliche Chancengleichheit, die den Fortschritt behindern.
Die Autoren betonen, dass obwohl wissenschaftliche Innovation und der Zugang zu Gesundheitsversorgung verbessert wurden, weltweit Millionen von Menschen weiterhin mit HIV leben. Sie fordern dringend Maßnahmen in den nächsten fünf Jahren, um bedeutende Fortschritte in der Prävention, beim Testen und in der Behandlung von HIV zu erreichen.
- Gilead Sciences commissioned a comprehensive report on global HIV epidemic elimination strategies
- The report provides a roadmap for countries to achieve the UN's 2030 HIV elimination goal
- The study identifies four key areas for national strategies to focus on for effective HIV management
- No country is close to achieving the UN's 2030 HIV elimination goal despite available resources
- Millions of people worldwide still live with HIV despite major advances in scientific innovation and healthcare access
- Social factors like stigma and discrimination continue to hinder progress in HIV prevention and treatment
NORTHAMPTON, MA / ACCESSWIRE / October 8, 2024 / In the early 2000s, Dr. Shannon Hader led the U.S. Centers for Disease Control and Prevention's collaboration with the Zimbabwe Ministry of Health that provided tens of thousands of people with much-needed HIV care.
Shannon, a public health and infectious disease specialist, returned to the United States in 2006 to witness a vastly different situation in the nation's capital. Washington, D.C. was facing a public health crisis with the highest rates of HIV in the nation. Shannon found that the district was resorting to an outdated HIV response system, so she prioritized the use of updated data and began introducing some of the innovative practices from the work in Africa to the work in the U.S.
"For a long time, it's been very easy to pretend that the wealthy countries are fine - that it's the non-wealthy countries that aren't doing well," she explains. "However, the reality is every single country in the world has more to do to help end the HIV epidemic. As the epidemic and tools evolve, our practices must evolve with them."
That's the crux of a new report, Going the Extra Mile to End the HIV Epidemic, that she helped author with Dr. Junko Tanuma of the National Center for Global Health and Medicine in Japan, and Mercy Shibemba, a health equity advocate for young people living with HIV in the UK. The report, commissioned and funded by Gilead, offers a roadmap that could help countries achieve the United Nations' goal of eliminating HIV by 2030. It also maintains that the tools are available to end the epidemic, but countries need to do more.
"There's really no reason why we can't achieve it," says Mercy. "But we're less than six years away from the United Nations' goal of eliminating HIV by 2030 - and no country is close to that goal, despite having the tools and resources that can help us get to zero."
To measure progress, the authors examined programs in nine Western countries, highlighting key takeaways from each nation's approach and potential areas for improvement. Despite major advances in scientific innovation, access to care and growth of health systems, there are still millions of people around the world living with HIV.
The report emphasizes the need to implement national strategies focused on four key areas. These include broader use of prevention, large-scale screening for diagnosis, expansion of community-based care and use of tools to measure quality of life and gauge success. It also examines the social factors that still stand in the way of progress, such as stigma, discrimination and health equity and access to care.
Mercy's own journey is an example of these obstacles, as she was born in 1998 with HIV but her sister, who is a few years younger, wasn't. "The thing that separated us was equity and access, which are key issues that can help end the epidemic," she says.
Mercy grew up worrying people would reject her if they discovered she was living with HIV. She believes it's this fear of stigma and discrimination that still prevents many from getting the care they need today.
Shannon agrees, noting, "HIV is also a social issue, therefore we need to meet people where they are to help overcome stigma and discrimination."
Now Dean of International Service at American University in Washington, D.C., Shannon regularly appeals to global leaders to help their communities work on progress in the prevention, testing and treatment of HIV within the next five years. She also looks to Gilead to continue to develop transformative therapies for those living with HIV and other diseases.
Both women reflect on what the epidemic could look like in 2030 and beyond, with Shannon saying hopefully, "My wish for you, Mercy, is that you'll know what it's like to live in a world where someday the epidemic has ended and there is a cure."
Originally published by Gilead Sciences
View additional multimedia and more ESG storytelling from Gilead Sciences on 3blmedia.com.
Contact Info:
Spokesperson: Gilead Sciences
Website: https://www.3blmedia.com/profiles/gilead-sciences
Email: info@3blmedia.com
SOURCE: Gilead Sciences
View the original press release on accesswire.com
FAQ
What is the main finding of the new report commissioned by Gilead Sciences (GILD) on HIV?
What are the four key areas for national HIV strategies identified in the Gilead Sciences (GILD) report?
Is any country close to achieving the UN's 2030 goal of eliminating HIV, according to the Gilead Sciences (GILD) report?
What social factors does the Gilead Sciences (GILD) report identify as hindering progress in HIV elimination?
